Gender
SHHS Visit Number vs Number of MIs Since Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Visit 1 | - | - | - | - | - | - | - | - |
Interim Follow-up Visit | 4,208 | 0.01 | ± 0.1 | 0.0 | 0.0 | 1.0 | 1,596 | 5,804 |
Visit 2 | - | - | - | - | - | - | - | - |
CVD Outcomes | 5,042 | 0.09 | ± 0.3 | 0.0 | 0.0 | 4.0 | 762 | 5,804 |
Gender vs Number of MIs Since Baseline
Interim Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 4,208 | 0.01 | ± 0.1 | 0.0 | 0.0 | 1.0 | 1,596 | 5,804 |
Male | 2,000 | 0.02 | ± 0.1 | 0.0 | 0.0 | 1.0 | 765 | 2,765 |
Female | 2,208 | 0.007 | ± 0.08 | 0.0 | 0.0 | 1.0 | 831 | 3,039 |
Gender vs Number of MIs Since Baseline
CVD Outcomes
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 5,042 | 0.09 | ± 0.3 | 0.0 | 0.0 | 4.0 | 762 | 5,804 |
Male | 2,349 | 0.1 | ± 0.4 | 0.0 | 0.0 | 4.0 | 416 | 2,765 |
Female | 2,693 | 0.07 | ± 0.3 | 0.0 | 0.0 | 4.0 | 346 | 3,039 |
Race vs Number of MIs Since Baseline
Interim Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 4,208 | 0.01 | ± 0.1 | 0.0 | 0.0 | 1.0 | 1,596 | 5,804 |
White | 3,738 | 0.01 | ± 0.1 | 0.0 | 0.0 | 1.0 | 1,169 | 4,907 |
Black | 328 | 0.009 | ± 0.1 | 0.0 | 0.0 | 1.0 | 187 | 515 |
Other | 142 | 0.0 | ± 0.0 | 0.0 | 0.0 | 0.0 | 240 | 382 |
Race vs Number of MIs Since Baseline
CVD Outcomes
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 5,042 | 0.09 | ± 0.3 | 0.0 | 0.0 | 4.0 | 762 | 5,804 |
White | 4,379 | 0.08 | ± 0.3 | 0.0 | 0.0 | 4.0 | 528 | 4,907 |
Black | 337 | 0.2 | ± 0.4 | 0.0 | 0.0 | 2.0 | 178 | 515 |
Other | 326 | 0.05 | ± 0.2 | 0.0 | 0.0 | 1.0 | 56 | 382 |